Cel-Sci Corporation Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (31)

Latest Posts

About This Stock More About This Stock
3 Small Biotech Stocks That Almost Doubled In Past Month
Article By: Zacks Investment Research
Tuesday, September 11, 2018 5:38 PM EDT
The biotech industry has seen a turnaround in the second half of 2018 after a slightly slower first half.
In this article: PRQR, CVM, EVFM Also: MRK, PFE, AMGN
Read
Is Cel-Sci The Cheapest Company In A Phase III Trial?
Article By: Peter Epstein
Monday, March 9, 2015 9:48 AM EDT
CEO Geert Kersten of Cel-Sci (CVM) believes his company's valuation is significantly below peers, some of which have drugs at the same or lower Stage. In this interview Mr. Kersten candidly addresses important questions about Cel-SciI.
In this article: CVM
Read
PlasmaTech Announces Reverse Stock Split, Launches New Corporate Website; CEL-SCI Announces Closing Of Public Offering
Article By: BioMedReports
Sunday, October 26, 2014 6:36 PM EDT
BioMed Reports takes a look at some of the headlines for companies that made news in the healthcare sector this week...
In this article: CVM, ACCP, SIMH, RDNT, TNDM, ACET, CUTR, MYGN, QLTI, ZFGN, HIIQ, HQY, ALDR, MCIG, OXFD, PINC
Read
Insider Trading Report Edition #185: Notable Insider Buys And Sales
Article By: Asif Suria
Monday, January 6, 2014 2:38 PM EDT
Notable Insider Buys: Opko Health, BioTime, Wheeler Real Estate Investment Trust, SP Plus Corp., and CEL-SCI. Notable Insider Sales: Monster Beverage Corp., Fidelity National Financial, FleetCor Technologies, Kodiak Oil & Gas Corp., and Groupon.
In this article: FLT, FNF, KOG, OPK, BTX, CVM, WHLRF, GRPN, MNST
Read

PARTNER HEADLINES

Latest Tweets for $CVM

No tweets yet!